cancer

With new data, Nkarta builds case for ‘natural killer’ cell therapy
BioPharma Dive
Mon, 12/5/22 - 10:45 am
Nkarta Therapeutics
cancer
blood cancer
natural killer cell therapies
NKX019
AstraZeneca Deepens Cancer Cell Therapy Portfolio with Neogene Buyout
BioSpace
Tue, 11/29/22 - 11:12 am
AstraZeneca
Neogene Therapeutics
M&A
cancer
cell therapy
Lilly backs $45M investment for mRNA cancer immunotherapy startup
Businesswire
Mon, 11/28/22 - 10:16 am
Strand Therapeutics
funding
Eli Lilly
rRNA
cancer
FogPharma’s $178M Funding Leads Way as 7 Biotechs Raise Cash for Cancer Drugs
MedCity News
Sun, 11/27/22 - 07:04 pm
FogPharma
funding
cancer
CatalYm
Roche
Opna Bio
Rezo Therapeutics
Hemispherian raises the first tranche of a Series A to fund the development of its novel cancer therapeutics
BioSpace
Sat, 11/26/22 - 07:22 pm
Hemispherian
funding
cancer
FogPharma hauls in $178M series D, the company’s second consecutive nine-digit financing round
Fierce Biotech
Mon, 11/21/22 - 07:20 pm
Fog Pharma
funding
cancer
Acrivon Nets $100M for Protein Tech That Picks Patients for Targeted Cancer Meds
MedCity News
Sun, 11/20/22 - 12:37 pm
Acrivon Therapeutics
Eli Lilly
IPOs
Proteomics
cancer
oncology
FDA wants confirmatory trials to be underway before granting accelerated cancer nods, Pazdur says
RAPS.org
Fri, 11/18/22 - 10:32 am
FDA
cancer
oncology
accelerated approvals
Richard Pazdur
Regeneron, CytomX Ink Potentially $2B Bispecific Immunotherapy Deal
BioSpace
Thu, 11/17/22 - 12:05 pm
Regeneron
CytomX Therapeutics
bispecifics
cancer
Veloci-Bi
drug development
Astellas' $1.3B antibody strikes first in hot cancer field, extending survival in phase 3
Fierce Biotech
Thu, 11/17/22 - 10:37 am
Astellas
zolbetuximab
clinical trials
cancer
gastric cancer
CureVac rethinks lead cancer program after posting PD-1 data, limiting future studies to mRNA vaccine combos
Fierce Biotech
Wed, 11/16/22 - 10:35 am
CureVac
vaccines
CV8102
MRNA
cancer
Baltimore Liquid Biopsy Startup Haystack Oncology Raises $56M in Series A Round
Bizjournals
Wed, 11/16/22 - 10:29 am
funding
Haystack Oncology
diagnostics
liquid biopsy
cancer
oncology
AstraZeneca and Sanofi win big as Europe's human medicines committee endorses approvals, label expansions
Fierce Pharma
Mon, 11/14/22 - 07:10 pm
Europe
AstraZeneca
Sanofi
COVID-19
cancer
GSK
Regeneron
mRNA non-vaccine therapeutics field set to reach $2 billion by 2028
Clinical Trials Arena
Tue, 11/8/22 - 10:54 am
MRNA
drug development
Moderna Therapeutics
Ultragenyx
Omega Therapeutics
BioNTech
cancer
OTX-2002
Report: Cancer deaths are down but pancreatic cancer is growing, racial disparities persist
MedCity News
Sun, 10/30/22 - 04:07 pm
cancer
pancreatic cancer
Sanofi reveals setback for cancer drug acquired in Synthorx buyout
BioPharma Dive
Fri, 10/28/22 - 10:56 am
Sanofi
Synthorx
M&A
SAR444245
cancer
Korean firm LG Chem buying AVEO Oncology for $566M
CP WIre
Tue, 10/18/22 - 01:57 pm
Aveo Oncology
M&A
oncology
cancer
Korea
LG Chem
Korean firm LG Chem buying AVEO Oncology for $566M
Tue, 10/18/22 - 01:55 pm
Aveo Oncology
M&A
oncology
cancer
Korea
LG Chem
Mablink Breaks into ADC Space with $30M for Improved Linker Tech
BioSpace
Sun, 10/16/22 - 05:14 pm
Mablink
antibody-drug conjugate
MBK-103
cancer
Cancer drug biotech Enliven shifts to reverse to move forward as a public company
MedCity News
Sun, 10/16/22 - 05:13 pm
Enliven Therapeutics
Imara
cancer
chronic myeloid leukemia

Pages